1. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010;Miller;Transfusion,2013
2. NCT00951808 Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE) https://clinicaltrials.gov/ct2/show/NCT00951808
3. Styles L Greene Wager C Labotka RJ Smith-Whitley K Thompson AA Lane PA Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10-13; San Diego, California 2011
4. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE);Styles;British Journal of Haematology,2012
5. Pain relief in the sickle-cell crisis: intravenous morphine versus ketorolac; a double-blind, randomized clinical trial;Doluee;Iranian Red Crescent Medical Journal,2019